The 2023 China Medical and Health Industry Symbiosis Conference, organized by Menet, a healthcare information platform, was grandly held in Huzhou from 27 to 30 July, 2023. A number of lists were released during the conference, including the “China Pharmaceutical Industry Top 100 Series List” and the “Most Valuable Product in Partnership for Drug Store […]
May 23, 2023, the Provincial Center for ADR Monitoring and the Provincial Medical Products Administration visited Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke Hefei”), a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), to conduct on-site assessment. More than 10 pharmaceutical enterprises in Hefei were also invited, including representative enterprises which manufacture […]
May 13, 2023, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) successfully held The 8th Pulmonary Arterial Hypertension Summit in Chongqing. With the theme of “Protecting Heart and Lungs For Health”, the forum aimed to promote academic exchanges at home and abroad, and to improve the diagnosis and treatment of pulmonary arterial hypertension. […]
May 9, 2023, the high-profile 86th PharmChina was grandly opened at the Qingdao International Expo Center on the theme “Building a new innovative and inclusive ecology of pharmaceutical and health”. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) participated in the event. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
April 24, 2023, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) announced that its in-licensed product Natulan® (Procarbazine Hydrochloride Capsules, formerly known as Procarbazine), was successfully launched in China and was distributed from its Guangzhou Nansha manufacturing site across the country. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
Recently, the Guangdong High-tech Association granted the certificates of “Guangdong Famous High-tech Products” for 2022. The Sodium Phenylbutyrate Granules, an in-house developed product of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), won the award by virtue of its outstanding innovation capacity, advanced technology, reliable quality and good market prospect. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: […]
Recently, Southern Metropolis Daily interviewed Dr. LI Xiao Yi Benjamin, the Founder and Director of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), to discuss the current situation of domestic ophthalmic disease treatment and drug market. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
On March 29, 2023, the preliminary bidding result of the eighth round of the national drug bulk-buying launched by the National Healthcare Security Administration was released. Zhaoke Pharmaceutical (Hefei) Company Limited, a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), participated in the bidding and its product Nadroparin Calcium Injection won […]
March 15, 2023, the Guangdong-Hong Kong-Macau Greater Bay Area New Direction for Economic Development Conference cum Gold Pilot Award 2022, co-organized by Hong Kong Trade Development Council (HKTDC) and Hong Kong Chamber of Commerce in Guangdong (HKCCGD) was successfully held in Shangri-La Hotel, Guangzhou. Guangzhou Zhaoke Lian Fa Pharmaceutical Limited, a subsidiary of Lee’s Pharmaceutical […]
Recently, the Hefei Municipal Government announced the result of the 8th Hefei City Industrial Achievements in Technology and Innovation. The development of Antiplatelet Thrombolysin by Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) was honoured with second prize. The representative of the Group attended the High-tech Industrial Development Zone Awards Ceremony and received […]
English 
Thai